Marijuana Abuse clinical trials
The registry lists 188 studies for Marijuana Abuse across more than 10 countries. 26 are recruiting or about to start. 127 of them are mainly about Marijuana Abuse (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the Marijuana Abuse studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Medical University of South Carolina (18) · New York State Psychiatric Institute (16) · National Institute on Drug Abuse (NIDA) (12) · Yale University (11) · Johns Hopkins University (6) · Wayne State University (6) · Aelis Farma (5) · Dartmouth-Hitchcock Medical Center (5)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 7
- Dec 2026Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning · Yale University
- Jan 2027RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders · Ciusss de L'Est de l'Île de Montréal
- Mar 2027A Mobile App to Reduce and/or Quit Cannabis Use · Alba González-Roz, PhD
- Mar 2027Impact of tDCS on Cannabis Craving in Schizophrenia · Centre hospitalier de Ville-Evrard, France
- May 2027Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use · Douglas Mental Health University Institute
- May 2027Cannabis and Processing Emotions Study · Auburn University
- Jun 2027Extended Effects of Cannabis Abstinence on Clinical Symptoms and Cognition in Depression · Centre for Addiction and Mental Health
Who these studies take
Of the 16 Marijuana Abuse studies recruiting now, 2 (13%) set no upper age limit and 13 (81%) stop at 75 or younger. 4 (25%) take children under 18. 0 (0%) are for women only and 1 (6%) for men only; 4 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 13 (81%) | 14 (88%) |
| 30 | 12 (75%) | 13 (81%) |
| 40 | 10 (63%) | 11 (69%) |
| 50 | 9 (56%) | 10 (63%) |
| 65 | 6 (38%) | 6 (38%) |
| 75 | 3 (19%) | 3 (19%) |
| 85 | 2 (13%) | 2 (13%) |
Across all 188 studies, recruiting or not: 82% stop at 75 or younger and 77% at 65; 20% take children; 4% are for women only and 3% for men only; 32% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Marijuana Abuse studies take
Of 11 phase 2 interventional studies under Marijuana Abuse, half reached primary completion within 31 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 2 | 31 mo23–42 · 11 studies | — | — |
| Interventional, no phase | 32 mo13–60 · 31 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting1
- Cannabis Association With Sleep StudyOct 19, 2026NCT06982950
Newly registered4
- Cardiopulmonary Complications of Electronic CigarettesNov 9, 2026NCT07924007
- A Hybrid Type 1 Randomized Controlled Trial of an Online and Text-Messaging Intervention to Prevent Alcohol and Cannabis Initiation, Escalation, and Consequences Among First-Year College StudentsOct 30, 2026NCT07905846
- An Investigation of Mechanisms That Underly Paranoia in Behaviour and Brain That Can Inform Clinical Diagnoses That Include Paranoid Symptoms.Oct 16, 2026NCT07878130
- Effects of Cannabidiol (CBD) on a Fixed Dose of Delta-9-tetrahydrocannabinol (THC)Oct 13, 2026NCT07870187
Studies
Recruiting first, then most recently updated. Showing 50 of 188. Browse all 188 → or search them.
- Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase PsychosisRecruitingNCT07056894Not applicable1 country
- Cannabis Abstinence and Neurocognitive Assessment in AdolescenceRecruitingNCT071601531 country
- QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)Not yet recruitingNCT07661823Not applicable1 country
- Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Cannabis Use DisorderNot yet recruitingNCT07838311Phase 41 country
- Evaluating the Delivery and Effects of THC Vaping Liquids in the BloodstreamNot yet recruitingNCT06334016Early Phase 11 country
- Lemborexant for Cannabis Use DisorderNot yet recruitingNCT07802990Phase 1/21 country
- Trial of Tirzepatide for the Treatment of Cannabis Use DisorderNot yet recruitingNCT07468552Phase 2
- Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis UseRecruitingNCT05445180Not applicable1 country
- Varenicline as a Treatment for Cannabis Use DisorderNot yet recruitingNCT07783555Phase 2
- Repeated CBD Administration and Cannabis OutcomesRecruitingNCT07434895Early Phase 11 country
- Applying Mixed Methods to Identify Links Between PTSD Symptoms, Cannabis Use, and Functional Behaviors With Personalized Feedback Intervention DevelopmentNot yet recruitingNCT07721285Not applicable1 country
- Neuroimaging of Adolescent Cannabis Use TreatmentRecruitingNCT07340554Not applicable1 country
- Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use DisorderRecruitingNCT07523633Phase 21 country
- Cannabis and Processing Emotions StudyRecruitingNCT06907979Not applicable1 country
- Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) ScanningRecruitingNCT017307811 country
- RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. InitiativeRecruitingNCT07184983Not applicable1 country
- Repetitive Transcranial Magnetic Stimulation for Cannabis Use DisorderRecruitingNCT05859347Not applicable1 country
- Cohort Study on Medical Students' Mental HealthRecruitingNCT073057011 country
- Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients With First Episode Psychosis (FEP)Not yet recruitingNCT07245212Not applicable1 country
- SCORE Emerging Adult Cannabis Use & StressRecruitingNCT05885542Phase 1/21 country
- Exercise Intervention as Treatment for People Using Cannabis (ExIT-C)RecruitingNCT07091292Not applicable1 country
- A Mobile App to Reduce and/or Quit Cannabis UseRecruitingNCT06733792Not applicable1 country
- Extended Effects of Cannabis Abstinence on Clinical Symptoms and Cognition in DepressionRecruitingNCT04935619Not applicable1 country
- Impact of tDCS on Cannabis Craving in SchizophreniaNot yet recruitingNCT05784961Not applicable1 country
- RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic DisordersRecruitingNCT05704582Not applicable1 country
- Characterization of the Pattern of Consumption and Withdrawal Syndrome From Dual Cannabis and Tobacco UseNot yet recruitingNCT05512091
- Psilocybin-assisted Treatment for Cannabis Use DisorderActive, not recruitingNCT06660381Phase 11 country
- A Trial of Guanfacine-er for Cannabis Use DisorderCompletedNCT05273567Phase 21 country
- Effects of Chronic Intake of Cannabis on Contrast SensitivityCompletedNCT01793961Not applicable1 country
- Drug-Drug Interaction Between THC and AEF0117WithdrawnNCT06395688Phase 1
- The Effect of Food on the Oral Bioavailability of AEF0117 in Healthy VolunteersTerminatedNCT05451017Phase 11 country
- The Neural Correlates of Cannabis UseCompletedNCT031042571 country
- Understanding Effects of Cannabis Use and Abstinence on Neural Glutamate HomeostasisTerminatedNCT05664763Early Phase 11 country
- Repetitive Transcranial Magnetic Stimulation to People With Cannabis Use Disorder (SToP-C-rTMS x CUD)CompletedNCT05292547Not applicable1 country
- Reducing Cannabis Overuse With PrazosinCompletedNCT04721353Phase 41 country
- Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility SpectrometryCompletedNCT053844701 country
- Joint Effort 2.0: a Mobile Application With University StudentsCompletedNCT05620433Not applicable1 country
- Investigating Real-world Stress-related Mechanisms in Heavy Cannabis UsersCompletedNCT05833230Not applicable1 country
- N-Acetylcysteine for Youth Cannabis Use DisorderCompletedNCT03055377Phase 2/31 country
- Implementing Screening for Cannabis and Other Drug Use Disorders in Primary Care: Impact on Diagnosis and TreatmentCompletedNCT06249542Not applicable
- Varenicline for Co-occurring Cannabis and Tobacco UseCompletedNCT04595318Phase 4
- Breathwork-assisted Treatment for Cannabis Use DisorderActive, not recruitingNCT05219825Not applicable1 country
- Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in VeteransWithdrawnNCT05294263Phase 21 country
- Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)CompletedNCT05322941Phase 21 country
- Substance Use Interventions for Truant AdolescentsCompletedNCT03655574Not applicable1 country
- Effects of Stress and Drug-cue Exposure (SCM)CompletedNCT03154567Phase 11 country
- Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis UsersCompletedNCT03154580Phase 11 country
- Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)CompletedNCT03056482Phase 41 country
- Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health DisordersActive, not recruitingNCT05726617Not applicable1 country
- UH3 Varenicline for Cannabis Use DisorderCompletedNCT03980561Phase 21 country